Skip to main content
Top
Published in:

01-12-2025 | Respiratory Microbiota | Review

Role of Gut Microbiome in Depression

Authors: Leena Grace Beslin, Fathima Humtha S, Anju R.F

Published in: Current Treatment Options in Neurology | Issue 1/2025

Login to get access

Abstract

Purpose of Review

The beneficial microbes or probiotics replace the hard treatment patterns in diverse arena. In the present review how we put-forth the good effects of advantageous microbes to accelerate the brain functions and suppression of gloominess in patients. Different innovative approaches especially the mood enchancement therapies to supress dipression were focused here.

Recent Findings

Gut microbiome diversity has been strongly associated with mood relating behaviors, including major depressive disorder (MDD). This association stems from the recently characterized bi-directional communication system between the gut and the brain, mediated by neuroimmune, neuroendocrine and sensory neural pathways. Gut microbes can engage “hardwired” neural signaling between gut and brain through interaction with the enteric nervous system (ENS) and vagus nerve. Gut microbes can modulate the activity of peripheral and central immune cells leading to altered behavior and stress responses. Alzheimer’s disease (AD) is the most common form of dementia, affecting millions of individuals each year and this number is expected to increase significantly. The complicated microorganisms residing in human gut are closely associated with our health.

Summary

Emerging evidence has suggested possible involvement of human gut microbiome in AD. Symbiotic gut microbiomes are known to maintain brain health by modulating host’s barriers integrity, metabolic system, immune system, nervous system and endocrine system. However, in the event of gut dysbiosis and barriers disruption, gut pathobionts disrupt homeostasis of the metabolic system, immune system, nervous system and endocrine system resulting in deterioration of neurological functions and subsequently uphold development of AD. Multiple therapeutic approaches such as fecal microbiome transplant, antibiotics, prebiotics, probiotics, symbiotic and diet basis are discussed as potential treatment options for AD by manipulating the gut microbiome to reverse pathological alteration in the systems.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Role of Gut Microbiome in Depression
Authors
Leena Grace Beslin
Fathima Humtha S
Anju R.F
Publication date
01-12-2025
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 1/2025
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-025-00825-x

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest